Filed: 2/7/2025ACC: 0000950142-25-000283
📋 What this filing means
GENERAL ATLANTIC, L.P. filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $2.81B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$2.81B
Total AUM (reported)
220.79M
Total Shares
Allocation by class
COM$1.37B48.9%
CL A$1.23B43.8%
ADS$207.00M7.4%
Portfolio Concentration
Top 3$1.76B62.6%
4–10$966.06M34.4%
11–25$83.69M3.0%
Top 3 weight
62.6%
Top 10 weight
97.0%
Voting Authority Distribution
Total shares with voting rights: 220.79M
Sole
Full voting authority
220.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
DLOCAL
SOLEShares63.91M
TypeSH
Market value$719.59M
25.61%
Sole
63.91M
Shared
0.00
None
0.00
ALIGNMENT HEALTHCARE
SOLEShares60.99M
TypeSH
Market value$686.17M
24.43%
Sole
60.99M
Shared
0.00
None
0.00
ALKAMI
SOLEShares9.65M
TypeSH
Market value$353.79M
12.59%
Sole
9.65M
Shared
0.00
None
0.00
XP, INC
SOLEShares29.62M
TypeSH
Market value$350.97M
12.49%
Sole
29.62M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS
SOLEShares9.68M
TypeSH
Market value$162.17M
5.77%
Sole
9.68M
Shared
0.00
None
0.00
AKERO THERAPEUTICS
SOLEShares5.23M
TypeSH
Market value$145.61M
5.18%
Sole
5.23M
Shared
0.00
None
0.00
PHARVARIS
SOLEShares7.53M
TypeSH
Market value$144.37M
5.14%
Sole
7.53M
Shared
0.00
None
0.00
EUROPEAN WAX CENTER
SOLEShares13.11M
TypeSH
Market value$87.45M
3.11%
Sole
13.11M
Shared
0.00
None
0.00
ROYALTY PHARMA
SOLEShares1.50M
TypeSH
Market value$38.27M
1.36%
Sole
1.50M
Shared
0.00
None
0.00
IMMUNOCORE
SOLEShares1.26M
TypeSH
Market value$37.22M
1.32%
Sole
1.26M
Shared
0.00
None
0.00
THIRD HARMONIC BIO
SOLEShares3.37M
TypeSH
Market value$34.70M
1.24%
Sole
3.37M
Shared
0.00
None
0.00
RISKIFIED
SOLEShares5.32M
TypeSH
Market value$25.19M
0.90%
Sole
5.32M
Shared
0.00
None
0.00
ACELYRIN
SOLEShares2.70M
TypeSH
Market value$8.46M
0.30%
Sole
2.70M
Shared
0.00
None
0.00
ADAGENE
SOLEShares3.83M
TypeSH
Market value$7.61M
0.27%
Sole
3.83M
Shared
0.00
None
0.00
WISH
SOLEShares609.62K
TypeSH
Market value$4.29M
0.15%
Sole
609.62K
Shared
0.00
None
0.00
GROVE COLLABORATIVE
SOLEShares2.47M
TypeSH
Market value$3.44M
0.12%
Sole
2.47M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DLOCALSOLE | CL A | 63.91M | SH | $719.59M 25.61% | 63.91M | 0.00 | 0.00 |
ALIGNMENT HEALTHCARESOLE | COM | 60.99M | SH | $686.17M 24.43% | 60.99M | 0.00 | 0.00 |
ALKAMISOLE | COM | 9.65M | SH | $353.79M 12.59% | 9.65M | 0.00 | 0.00 |
XP, INCSOLE | CL A | 29.62M | SH | $350.97M 12.49% | 29.62M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALSSOLE | ADS | 9.68M | SH | $162.17M 5.77% | 9.68M | 0.00 | 0.00 |
AKERO THERAPEUTICSSOLE | COM | 5.23M | SH | $145.61M 5.18% | 5.23M | 0.00 | 0.00 |
PHARVARISSOLE | COM | 7.53M | SH | $144.37M 5.14% | 7.53M | 0.00 | 0.00 |
EUROPEAN WAX CENTERSOLE | CL A | 13.11M | SH | $87.45M 3.11% | 13.11M | 0.00 | 0.00 |
ROYALTY PHARMASOLE | CL A | 1.50M | SH | $38.27M 1.36% | 1.50M | 0.00 | 0.00 |
IMMUNOCORESOLE | ADS | 1.26M | SH | $37.22M 1.32% | 1.26M | 0.00 | 0.00 |
THIRD HARMONIC BIOSOLE | COM | 3.37M | SH | $34.70M 1.24% | 3.37M | 0.00 | 0.00 |
RISKIFIEDSOLE | CL A | 5.32M | SH | $25.19M 0.90% | 5.32M | 0.00 | 0.00 |
ACELYRINSOLE | COM | 2.70M | SH | $8.46M 0.30% | 2.70M | 0.00 | 0.00 |
ADAGENESOLE | ADS | 3.83M | SH | $7.61M 0.27% | 3.83M | 0.00 | 0.00 |
WISHSOLE | CL A | 609.62K | SH | $4.29M 0.15% | 609.62K | 0.00 | 0.00 |
GROVE COLLABORATIVESOLE | CL A | 2.47M | SH | $3.44M 0.12% | 2.47M | 0.00 | 0.00 |